As of December 2024, PharmaCyte Biotech has a market cap of $14.13M. This makes PharmaCyte Biotech the world's 29716th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $17.83M | -4.17% |
2023 | $18.61M | -26.28% |
2022 | $25.24M | 17.20% |
2021 | $21.54M | -75.93% |
2020 | $89.47M | -83.46% |
2019 | $540.85M | 9.46% |
2018 | $494.11M | -33.69% |
2017 | $745.17M | -62.53% |
2016 | $1.99B | 223.70% |
2015 | $614.30M | -74.44% |
2014 | $2.40B | 76.47% |
2013 | $1.36B | - |